13G Filing: Biotechnology Value Fund L P and Arqule Inc (ARQL)

Page 14 of 14

Page 14 of 14 – SEC Filing

SIGNATURE

After reasonable inquiry
and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement
is true, complete and correct.

Dated: October 16, 2017

BIOTECHNOLOGY VALUE FUND, L.P. BVF INC.
 
By: BVF Partners L.P., its general partner By:

/s/ Mark N. Lampert

By: BVF Inc., its general partner Mark N. Lampert
  President
By:

/s/ Mark N. Lampert

Mark N. Lampert
President

/s/ Mark N. Lampert

  MARK N. LAMPERT
 
BIOTECHNOLOGY VALUE FUND II, L.P.
 
By: BVF Partners L.P., its general partner
By: BVF Inc., its general partner
 
By:

/s/ Mark N. Lampert

Mark N. Lampert
President
BVF PARTNERS L.P.
By: BVF Inc., its general partner
 
By:

/s/ Mark N. Lampert

Mark N. Lampert
President
BVF PARTNERS OS LTD.
By: BVF Partners L.P., its sole member
By: BVF Inc., its general partner
 
By:

/s/ Mark N. Lampert

Mark N. Lampert
President
14

Follow Arqule Inc (NASDAQ:ARQL)

Page 14 of 14